Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Pazopanib

Irreversible acute heart failure and reversible acute heart failure

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kertmen N, et al. Acute heart failure following pazopanib treatment: a literature review featuring two case reports. Anti-Cancer Drugs 35: 302-304, No. 3, Mar 2024. Available from: URL: https://dx.doi.org/10.1097/CAD.0000000000001560 [Summarised from an abstract] Kertmen N, et al. Acute heart failure following pazopanib treatment: a literature review featuring two case reports. Anti-Cancer Drugs 35: 302-304, No. 3, Mar 2024. Available from: URL: https://​dx.​doi.​org/​10.​1097/​CAD.​0000000000001560​ [Summarised from an abstract]
Metadaten
Titel
Pazopanib
Irreversible acute heart failure and reversible acute heart failure
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55318-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Elasomeran